Clinical Trials Browser

Phase 2/3 × Esophageal Squamous Cell Carcinoma × nimotuzumab × Clear all

NCT02272699 2021-03-18

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Phase 2/3 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01402180 2011-07-26

Nimotuzumab

Phase 2/3 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma